Novo nordisk: An ecosystem approach to preventing diabetes

Abstract

Novo Nordisk, the Danish multinational pharmaceutical company, has taken an innovative approach to addressing diabetes around the world in a programme known as ‘Cities Changing Diabetes’. This involves partnering with patients, policymakers, health-care professionals and non-government organizations to find policies based on life-style changes that help people living in urban environments to avoid, manage, and treat the onset of type 2 diabetes. Community engagement with health, health-promoting policies, and health-system strengthening were the types of initiatives that were trialled, and impact measurements were undertaken to evaluate the performance of the programme.